<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31877138</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Dynamic changes of soluble ST2 levels predicted fatality and were involved in coagulopathy in dengue fever in the elderly.</ArticleTitle><Pagination><StartPage>e0007974</StartPage><MedlinePgn>e0007974</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0007974</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0007974</ELocationID><Abstract><AbstractText Label="BACKGROUND">Severe dengue virus (DENV) infection involves plasma leakage and vascular collapse, and leads to significant morbidity and death. Serum soluble ST2 (sST2 [interleukin (IL)-1 receptor like-1 protein: IL-1-RL-1]) levels are high in pediatric cases of DENV infection, and the disease progresses. However, the correlation between serum sST2 levels and the outcomes of DENV infection in the elderly (&#x2265;65 years) is unclear. We thus explored the mechanisms of serial sST2 level changes involved in the coagulopathy and bloodstream infections of elderly patients in Taiwan's 2015 DENV outbreak.</AbstractText><AbstractText Label="METHODS">This retrospective study was done in a tertiary medical center in southern Taiwan during the outbreak. All DENV-infected patients who, between July 1, 2015, and December 31, 2015, provided a written informed consent for at least two blood sample analyses were enrolled and reviewed. The serum levels of sST2 were quantified. &#x394;sST2 is defined as the "changes of sST2 levels in serially paired samples". Receiver operating characteristic (ROC) curve and area under the ROC curve (AUC) analyses were used to evaluate the prognostic ability of &#x394;sST2.</AbstractText><AbstractText Label="RESULTS">Forty-three patients with DENV infection were enrolled. Mean patient age was 75.0 &#xb1; 12.2 years and the case fatality rate was 44.2% (19/43). Significantly more non-survivors than survivors had increased ST2 level (78.9% vs. 12.5%, p &lt; 0.001). The AUC value for serum &#x394;sST2 level was 0.857 for predicting DENV fatality. Moreover, patients given frozen fresh plasma (FFP) transfusions were significantly (p = 0.025) more likely to have higher serum ST2 level changes than were those who had not. DENV-infected patients with early bloodstream infections (BSIs) seemed to have higher ST2 levels than those who did not have BSIs.</AbstractText><AbstractText Label="CONCLUSIONS">Serum ST2 levels increased in the elderly (&#x2265; 65 years of age) with DENV infection. The changes in serum sST2 levels might be a critical indicator of DENV infection severity for the elderly; sST2 is an important modulator of coagulopathy in severe DENV infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chih-Cheng</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0003-2742-3268</Identifier><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Ming-Yuan</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Chuan</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey-Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Chia-Chang</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0003-0481-2949</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C079241">IL1RL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072179">Interleukin-1 Receptor-Like 1 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003955" MajorTopicYN="N">Diagnostic Tests, Routine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072179" MajorTopicYN="N">Interleukin-1 Receptor-Like 1 Protein</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31877138</ArticleId><ArticleId IdType="pmc">PMC6948823</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0007974</ArticleId><ArticleId IdType="pii">PNTD-D-19-00149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Dengue guidelines for diagnosis, treatment, prevention and control: new edition. Geneva: World Health Organization; 2009.</Citation></Reference><Reference><Citation>WHO. Comprehensive guidelines for prevention and control of dengue fever and dengue haemorrhagic fever. SEARO, New Delhi, India: World Health Organization; 2011.</Citation></Reference><Reference><Citation>Yeh CY, Chen PL, Chuang KT, Shu YC, Chien YW, Perng GC, et al. Symptoms associated with adverse dengue fever prognoses at the time of reporting in the 2015 dengue outbreak in Taiwan. PLoS neglected tropical diseases. 2017;11(12):e0006091 Epub 2017/12/07. 10.1371/journal.pntd.0006091</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006091</ArticleId><ArticleId IdType="pmc">PMC5718413</ArticleId><ArticleId IdType="pubmed">29211743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CC, Cia CT, Lee JC, Sung JM, Lee NY, Chen PL, et al. A cohort study of adult patients with severe dengue in Taiwanese intensive care units: The elderly and APTT prolongation matter for prognosis. PLoS neglected tropical diseases. 2017;11(1):e0005270 Epub 2017/01/07. 10.1371/journal.pntd.0005270</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005270</ArticleId><ArticleId IdType="pmc">PMC5245902</ArticleId><ArticleId IdType="pubmed">28060934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CM, Chan KS, Yu WL, Cheng KC, Chao HC, Yeh CY, et al. The outcomes of patients with severe dengue admitted to intensive care units. Medicine. 2016;95(31):e4376 Epub 2016/08/09. 10.1097/MD.0000000000004376</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004376</ArticleId><ArticleId IdType="pmc">PMC4979801</ArticleId><ArticleId IdType="pubmed">27495047</ArticleId></ArticleIdList></Reference><Reference><Citation>Syue LS, Tang HJ, Hung YP, Chen PL, Li CW, Li MC, et al. Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2019;52(2):225&#x2013;32. Epub 2018/12/12. 10.1016/j.jmii.2018.11.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2018.11.003</ArticleId><ArticleId IdType="pubmed">30528336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. The American journal of tropical medicine and hygiene. 1993;48(3):324&#x2013;31. Epub 1993/03/01. 10.4269/ajtmh.1993.48.324 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1993.48.324</ArticleId><ArticleId IdType="pubmed">8470771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. The Journal of clinical investigation. 1991;88(5):1473&#x2013;80. 10.1172/JCI115457</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI115457</ArticleId><ArticleId IdType="pmc">PMC295652</ArticleId><ArticleId IdType="pubmed">1939640</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, et al. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. Journal of virology. 2007;81(4):1592&#x2013;600. 10.1128/JVI.01642-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01642-06</ArticleId><ArticleId IdType="pmc">PMC1797579</ArticleId><ArticleId IdType="pubmed">17151115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur P, Kaur G. Transfusion support in patients with dengue fever. Int J Appl Basic Med Res. 2014;4(Suppl 1):S8&#x2013;S12. Epub 2014/10/10. 10.4103/2229-516X.140708</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2229-516X.140708</ArticleId><ArticleId IdType="pmc">PMC4181139</ArticleId><ArticleId IdType="pubmed">25298950</ArticleId></ArticleIdList></Reference><Reference><Citation>Houghton-Trivino N, Salgado DM, Rodriguez JA, Bosch I, Castellanos JE. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation. The Journal of general virology. 2010;91(Pt 3):697&#x2013;706. Epub 2009/11/06. 10.1099/vir.0.012971-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.012971-0</ArticleId><ArticleId IdType="pubmed">19889931</ArticleId></ArticleIdList></Reference><Reference><Citation>Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine. 2008;41(2):114&#x2013;20. 10.1016/j.cyto.2007.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2007.11.001</ArticleId><ArticleId IdType="pmc">PMC2276732</ArticleId><ArticleId IdType="pubmed">18226917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. The American journal of tropical medicine and hygiene. 2006;74(1):142&#x2013;7. Epub 2006/01/13. .</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti A, Kumaria R. Circulating levels of tumour necrosis factor-alpha &amp; interferon-gamma in patients with dengue &amp; dengue haemorrhagic fever during an outbreak. The Indian journal of medical research. 2006;123(1):25&#x2013;30. .</Citation><ArticleIdList><ArticleId IdType="pubmed">16567864</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R, et al. Elevated levels of IL-8 in dengue hemorrhagic fever. Journal of medical virology. 1998;56(3):280&#x2013;5. 10.1002/(sici)1096-9071(199811)56:3&lt;280::aid-jmv18&gt;3.0.co;2-i .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1096-9071(199811)56:3&lt;280::aid-jmv18&gt;3.0.co;2-i</ArticleId><ArticleId IdType="pubmed">9783699</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol. 2010;338:67&#x2013;82. Epub 2009/10/06. 10.1007/978-3-642-02215-9_6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-02215-9_6</ArticleId><ArticleId IdType="pubmed">19802579</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE. 2003;2003(171):re3 10.1126/stke.2003.171.re3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/stke.2003.171.re3</ArticleId><ArticleId IdType="pubmed">12606705</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero CD, Arrieta AF, Ramirez ND, Rodr&#xed;guez L-S, Vega R, Bosch I, et al. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine. 2013;61(3):766&#x2013;71. 10.1016/j.cyto.2012.12.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.12.024</ArticleId><ArticleId IdType="pubmed">23357301</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer G, Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol. 2011;7(6):321&#x2013;9. 10.1038/nrrheum.2011.53 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2011.53</ArticleId><ArticleId IdType="pubmed">21519352</ArticleId></ArticleIdList></Reference><Reference><Citation>Trajkovic V, Sweet MJ, Xu D. T1/ST2&#x2014;an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 2004;15(2&#x2013;3):87&#x2013;95. 10.1016/j.cytogfr.2004.02.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2004.02.004</ArticleId><ArticleId IdType="pubmed">15110792</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical care medicine. 1985;13(10):818&#x2013;29. Epub 1985/10/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Critical care medicine. 1998;26(11):1793&#x2013;800. Epub 1998/11/21. 10.1097/00003246-199811000-00016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199811000-00016</ArticleId><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. American journal of respiratory and critical care medicine. 2001;164(2):277&#x2013;81. Epub 2001/07/21. 10.1164/ajrccm.164.2.2008120 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.164.2.2008120</ArticleId><ArticleId IdType="pubmed">11463601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroiwa K, Arai T, Okazaki H, Minota S, Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochemical and biophysical research communications. 2001;284(5):1104&#x2013;8. 10.1006/bbrc.2001.5090 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2001.5090</ArticleId><ArticleId IdType="pubmed">11414697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacker S, Dieplinger B, Werba G, Nickl S, Roth GA, Krenn CG, et al. Increased serum concentrations of soluble ST2 predict mortality after burn injury. Clinical chemistry and laboratory medicine: CCLM / FESCC. 2018. 10.1515/cclm-2018-0042 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2018-0042</ArticleId><ArticleId IdType="pubmed">29949506</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Meara E, Prescott MF, Claggett B, Rouleau JL, Chiang LM, Solomon SD, et al. Independent prognostic value of serum soluble ST2 measurements in patients with heart failure and a reduced ejection fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circulation Heart failure. 2018;11(5):e004446 10.1161/CIRCHEARTFAILURE.117.004446 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.117.004446</ArticleId><ArticleId IdType="pubmed">29748349</ArticleId></ArticleIdList></Reference><Reference><Citation>Boman K, Thormark Frost F, Bergman AR, Olofsson M. NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2018;23(4):373&#x2013;9. 10.1080/1354750X.2018.1431692 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1354750X.2018.1431692</ArticleId><ArticleId IdType="pubmed">29355441</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, Lin YS, et al. Activation of coagulation and fibrinolysis during dengue virus infection. Journal of medical virology. 2001;63(3):247&#x2013;51. 10.1002/1096-9071(200103)63:3&lt;247::aid-jmv1008&gt;3.0.co;2-f .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200103)63:3&lt;247::aid-jmv1008&gt;3.0.co;2-f</ArticleId><ArticleId IdType="pubmed">11170065</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PP, Zhang XM, Yuan D, Liu X, Li Y, Shan NN. Decreased expression of IL-33 in immune thrombocytopenia. Int Immunopharmacol. 2015;28(1):420&#x2013;4. Epub 2015/07/15. 10.1016/j.intimp.2015.06.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.06.035</ArticleId><ArticleId IdType="pubmed">26164496</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojkovic S, Kaun C, Basilio J, Rauscher S, Hell L, Krychtiuk KA, et al. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Scientific reports. 2016;6:25171 Epub 2016/05/05. 10.1038/srep25171</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25171</ArticleId><ArticleId IdType="pmc">PMC4855148</ArticleId><ArticleId IdType="pubmed">27142573</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med (Maywood). 2011;236(5):515&#x2013;23. Epub 2011/04/20. 10.1258/ebm.2011.010339 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2011.010339</ArticleId><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Thein TL, Ng EL, Yeang MS, Leo YS, Lye DC. Risk factors for concurrent bacteremia in adult patients with dengue. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2017;50(3):314&#x2013;20. Epub 2015/09/05. 10.1016/j.jmii.2015.06.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2015.06.008</ArticleId><ArticleId IdType="pubmed">26338309</ArticleId></ArticleIdList></Reference><Reference><Citation>Intke C, Korpelainen S, Hamalainen S, Vanska M, Koivula I, Jantunen E, et al. Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients. Eur J Haematol. 2018. 10.1111/ejh.13161 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.13161</ArticleId><ArticleId IdType="pubmed">30099772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>